Linking solubility and permeability assays for maximum throughput and reproducibility

Journal of Biomolecular Screening

Volumn 10, Issue 4, 2005, Pages 383-390

  Wexler, David S ^a   Gao, Liping ^a   Anderson, Francisco ^a   Ow, Arnold ^a   Nadasdi, Laszlo ^a   McAlorum, Alanna ^a   Urfer, Roman ^a   Huang, Shu Gui ^a  

^a AGY Therapeutics Inc   (United States)

Author keywords

ADME Tox; Blood brain barrier; High throughput; PAMPA

Indexed keywords

4 AMINO 1 (6 CHLORO 2 PYRIDYL)PIPERIDINE; AMITRIPTYLINE; CAFFEINE; CARBAMAZEPINE; CLONIDINE; DESIPRAMINE; DEXTRORPHAN; DICLOFENAC; DIZOCILPINE; FLUVOXAMINE; ISOXICAM; LOMEFLOXACIN; LOPERAMIDE; N TERT BUTYL ALPHA PHENYLNITRONE; PHENAZOPYRIDINE; PIROXICAM; PROPRANOLOL; QUIPAZINE; RANITIDINE; THEOPHYLLINE; VERAPAMIL; ZOLANTIDINE;

ARTICLE; BLOOD BRAIN BARRIER; COMPARATIVE STUDY; DRUG ABSORPTION; DRUG PENETRATION; DRUG SOLUBILITY; GASTROINTESTINAL TRACT; HIGH THROUGHPUT SCREENING; MEMBRANE PERMEABILITY; MEMBRANE TRANSPORT; PRIORITY JOURNAL; REPRODUCIBILITY;

BLOOD-BRAIN BARRIER; GASTROINTESTINAL TRACT; PERMEABILITY; PHARMACOKINETICS; REPRODUCIBILITY OF RESULTS; SOLUBILITY;

EID: 20444411476     PISSN: 10870571     EISSN: None     Source Type: Journal    
DOI: 10.1177/1087057105274785     Document Type: Article

References (32)

1. Kilpatrick P: Pressures in the pipeline. Nat Rev Drug Discov 2003;2:337.
2. Avdeef A: Physicochemical profiling (solubility, permeability, and charge state). Curr Top Med Chem 2001;1:277-351.
3. Avdeef A: Absorption and Drug Development: Solubility, Permeability, and Charge State. Hoboken, NJ: John Wiley & Sons, 2003.
4. Bohets H, Annaert P, Mannens G, van Beijsterveldt L, Anciaux K, Verboven P, et al: Strategies for absorption screening in drug discovery and development. Curr Top Med Chem 2001;1:367-383.
5. Sun D, Yu LX, Hussain MA, Wall DA, Smith RL, Amidon GL: In vitro testing of drug absorption for drug "developability" assessment: forming an interface between in vitro preclinical data and clinical outcome. Curr Opin Drug Discov Devel 2004;7:75-85.
6. Hidalgo IJ: Assessing the absorption of new pharmaceuticals. Curr Top Med Chem 2001;1:385-401.
7. Levy RH, Rowland M: Dissociation constants of sparingly soluble substances: non-logarithmic linear titration curves. J Pharm Sci 1971;60:1155-1159.
8. Charykov AK, Tal'nikova TV: pH-metric method of determining the solubility and distribution ratios of some organic compounds in extraction systems. J Anal Chem 1974;29:818-822.
9. Faller B, Wohnsland F: Physicochemical parameters as tools in drug discovery and lead optimization. In Testa B, van de Waterbeemd H, Folkers G, Guy R (eds): Pharmacokinetics Optimization in Drug Research. Zurich. Switzerland: Verlag Helvitica Chimica Acta, 2001:257-274.
10. Bevan CD, Lloyd RS: A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates. Anal Chem 2000;72:1781-1787.
11. Hayward MJ, Hargiss LO, Munson JL, Mandiyan SP, Wennogle LP: Validation of solubility measurements using ultra-filtration liquid chromatography mass spectrometry (UF-LC/MS). Paper presented at the 48th annual conference on Mass Spectrometry and Allied Topics, Long Beach, CA, 2000:AM10:55.
12. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ: Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001;23:3-26.
13. Avdeef A: High throughput measurements of solubility profiles. In Testa B, van de Waterbeemd H, Folkers G, Guy R (eds): Pharmacokinetics Optimization in Drug Research. Zurich, Switzerland: Verlag Helvitica Chimica Acta, 2001:305-326.
14. Mason RP, Rhodes DG, Herbette LG: Reevaluating equilibrium and kinetic binding parameters from lipophilic drugs based on a structural model for drug interactions with biological membranes. J Med Chem 1991;34:869-877.
15. Herbette LG, Rhodes DG, Mason RP: New approaches to drug design and delivery based on drug-membrane interactions. Drug Des Deliv 1991;7:75-118.
16. Austin RP, Davis AM, Manners CN: Partitioning of ionizing molecules between aqueous buffers and phospholipids vesicle. J Pharm Sci 1995;84:1180-183.
17. Balon K, Riebesehl BU, Muller BW: Drug liposome partitioning as a tool for the prediction of human passive intestinal absorption. Pharm Res 1999;16:882-888.
18. Kansey M, Senner F, Gubernator K: Physicochemical high throughput screening: parallel artificial permeation assay in the description of passive absorption processes. J Med Chem 1998;41:1007-1010.
19. Artursson P, Karlsson J: Correlation between oral absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco2) cells. Biochem Biophys Res Commun 1991;175:880-885.
20. Yee S: In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man-fact or myth? Pharm Res 1997;14:763-766.
21. Sugano K, Hamada H, Machida M, Ushio H: High throughput prediction of oral absorption: improvement of the composition of the lipid solution used in parallel artificial membrane permeability assay. J Biomol Screen 2001;6:189-196.
22. Sugano K, Hamada H, Machida M, Ushio H, Saitoh K, Terada K: Optimized conditions of biomimetic artificial membrane permeability assay. Int J Pharm 2001;228:181-188.
23. Wohlsland F, Faller B: High-throughput permeability pH profile and high-throughput alkane/water logP with artificial membranes. J Med Chem 2001;44:923-930.
24. Zhu C, Jiang L, Chen T-M, Hwang K-K: A comparative study of artificial membrane permeability assay for high-throughput profiling of drug absorption potential. Eur J Med Chem 2002;37:399-407.
25. Di L, Kerns EH, Fan K, McConnell OJ, Carter GT: High throughput artificial membrane permeability assay for blood-brain barrier. Eur J Med Chem 2003;38:223-232.
26. Millipore Corporation: Multiscreen solubility filter plate: determination of aqueous compound solubility using a 96-well filter plate to remove precipitated solids prior to UV/Vis spectroscopic analysis. Millipore Corporation protocol note PC2445EN00.
27. Molecular Devices: Making optical density measurements automatically corrected to a 1cm pathlength in the SPECTRAmaxPLUS microplate spectrophotometer. Application Note 25: 0120-1120A.
28. Avdeef A, Berger CM, Brownell C: pH-metric solubility. 2: correlation between the acid-base titration and the saturation shake-flask solubility pH methods. Pharm Res 2000;17:85-89.
29. Sugano K, Nabuchi Y, Machida M, Aso Y: Prediction of human intestinal permeability using artificial membrane permeability. Int J Pharm 2003;257:245-251.
30. flux-optimized design (pOD-PAMPA). Eur J Pharm Sci 2003;20:393-402.
31. McCall AL, Millington WR, Wurtman RJ: Blood-brain barrier transport of caffeine: dose-related restriction of adenine transport. Life Sci 1982;31:2709-2715.
32. Kelder J, Grootenhuis PDJ, Bayada DM, Delbressine LPC, Ploemen JP: Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs. Pharm Res 1999;16:1514-1519.